CompaniesChurchill Pharmaceuticals

Churchill Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

2

By Phase

PHASE3: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
Today
NCT02887976
Hover over trial bars to see details

Recent Trials

NCT02887976Collaborator
Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201
PHASE3Completed
2 participants
Started: Sep 30, 2016 · Completed: Oct 6, 2017